Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
GLP-1RAs show promise in managing RA and cardiometabolic health The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) was associated with improvements in both rheumatoid arthritis (RA) disease activity and cardiovascular risk factors among people living with overweight or obesity, according to new research published in ACR Open Rheumatology
Food and Drug Administration (FDA) in May 2022 for the treatment of type 2 diabetes [1]
The potential side effects of GLP-1 drugs are no fun: nausea, vomiting, fatigue, diarrhea, constipation
The practical rule: choose a concentration that puts your weekly dose in a 0.1ml0.4ml injection volume
US$ 21.38
US$ 26.85
US$ 24.48
US$ 25.17
